Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

IEC 60601 Changes Include Risk Management In Device Development Process

This article was originally published in The Gray Sheet

Executive Summary

The third edition of the International Engineering Consortium's 60601 set of standards for electromedical equipment will incorporate a risk management approach into the medical device development process as part of the industry's continuing effort to harmonize global standards and streamline regulatory approval processes.

You may also be interested in...



IEC Electromedical Safety Standard Third Edition Expected In August 2005

Manufacturers planning declarations of conformity to the third edition of the International Engineering Consortium's electromedical equipment standard should come into compliance with international risk management standard ISO 14971, panelists at a recent AAMI/FDA meeting suggested

At-Home Health Testing Demand Is High Post-Pandemic, But So Are Barriers To Development And Use

At the recent Precision Med-Tri Con conference, laboratory experts traded views on the expansion of at-home testing for disease diagnosis and personalized health insights. While strong consumer demand spells opportunity, there are significant concerns about the accuracy and reliability of home-testing platforms, misuse, accessibility, and lack of health literacy.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT011530

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel